The Chinese Medical Nutrition Treatment Guidelines for Overweight/Obesity (2021) include an LGID as one of the diets that are suitable for the treatment of overweight and obesity and indicates that such a diet is beneficial with respect to weight loss, satiety, and insulin resistance, which is consistent with the results of the present study. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.